Dr. Soliman Abdul Kader Fakeeh Hospital Co. vs HCA Healthcare, Inc.
A head-to-head of Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017) and HCA Healthcare, Inc. (HCA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Dr. Soliman Abdul Kader Fakeeh Hospital Co.
4017
34.76 SAR
-1.03%
VS
HCA Healthcare, Inc.
HCA
$371.18
-3.77%
| Metric | 4017 | HCA |
|---|---|---|
| Market Cap | 8.01B SAR | $82.34B |
| P/E (TTM) | 30.23 | 12.76 |
| Forward P/E | 21.07 | 13.11 |
| P/S | 2.59 | 1.26 |
| P/B | 2.51 | -16.19 |
| EV/EBITDA | 22.21 | 9.68 |
| Dividend Yield | — | 0.83% |
| Profit Margin | 8.77% | 8.89% |
| Gross Margin | 19.32% | 41.50% |
| Operating Margin | 6.16% | 15.83% |
| Revenue Growth (YoY) | -2.50% | +4.30% |
| FCF Yield | -2.30% | 8.22% |
| Debt / Equity | 20.66 | — |
| Current Ratio | 1.65 | 0.83 |
Which is better: Dr. Soliman Abdul Kader Fakeeh Hospital Co. or HCA Healthcare, Inc.?
- ✓Larger by market cap: HCA Healthcare, Inc.
- ✓Cheaper valuation (lower P/E): HCA Healthcare, Inc.
- ✓More profitable (net margin): HCA Healthcare, Inc.
- ✓Faster revenue growth: HCA Healthcare, Inc.
- ✓Higher free-cash-flow yield: HCA Healthcare, Inc.
Across 10 available metrics, HCA Healthcare, Inc. leads 9–1.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Dr. Soliman Abdul Kader Fakeeh Hospital Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.